Abstract
After the outbreak of COVID-19, many novel drugs have been introduced to improve patients’ conditions. Remdesivir and Favipiravir are among the most common drugs used against SARS-CoV-2. Although promising, cardiovascular side effects of these drugs should be considered by physicians and nurses. In this study, we searched databases for assessing the cardiovascular side effects of Remdesivir and Favipiravir. It seems that despite the beneficial effects of these drugs, due to the cardiovascular complications of COVID-19 and cardiovascular side effects of these drugs, which can overlap with each other, the use of these drugs can be a challenging issue in the cardiovascular practice.
Keywords: Remdesivir, favipiravir, COVID-19, heart, cardiovascular, side effect.
Cardiovascular & Hematological Disorders-Drug Targets
Title:Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19
Volume: 21 Issue: 2
Author(s): Mohammad Amin Shahrbaf, Mohammadreza Tabary and Isa Khaheshi*
Affiliation:
- Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran,Iran
Keywords: Remdesivir, favipiravir, COVID-19, heart, cardiovascular, side effect.
Abstract: After the outbreak of COVID-19, many novel drugs have been introduced to improve patients’ conditions. Remdesivir and Favipiravir are among the most common drugs used against SARS-CoV-2. Although promising, cardiovascular side effects of these drugs should be considered by physicians and nurses. In this study, we searched databases for assessing the cardiovascular side effects of Remdesivir and Favipiravir. It seems that despite the beneficial effects of these drugs, due to the cardiovascular complications of COVID-19 and cardiovascular side effects of these drugs, which can overlap with each other, the use of these drugs can be a challenging issue in the cardiovascular practice.
Export Options
About this article
Cite this article as:
Shahrbaf Amin Mohammad, Tabary Mohammadreza and Khaheshi Isa*, Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19, Cardiovascular & Hematological Disorders-Drug Targets 2021; 21 (2) . https://dx.doi.org/10.2174/1871529X21666210812103535
DOI https://dx.doi.org/10.2174/1871529X21666210812103535 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Dietary Non-Fiber Carbohydrates on Composition and Function of Gut Microbiome in Monogastrics: A Review
Protein & Peptide Letters Triggered, Nanostructured Biodegradables (TNBs) for Surgical Implants
Micro and Nanosystems NF-κB Signaling and Carcinogenesis
Current Pharmaceutical Design Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition with Canagliflozin in Type 2 Diabetes Mellitus
Cardiovascular & Hematological Agents in Medicinal Chemistry The Deadly Quartet (Covid-19, Old Age, Lung Disease, and Heart Failure) Explains Why Coronavirus-Related Mortality in Northern Italy Was So High
Current Cardiology Reviews The Role of Heat Shock Protein (HSP) in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Medicinal Chemistry Potential Cardio-Protective Agents: A Resveratrol Review (2000-2019)
Current Pharmaceutical Design Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases
Current Topics in Medicinal Chemistry The Biphasic Virulence Activities of Gingipains: Activation and Inactivation of Host Proteins
Current Protein & Peptide Science Apoptosis: Potential Therapeutic Targets for New Drug Discovery
Current Medicinal Chemistry Clinical Applications of Positron Emission Tomography (PET) Imaging in Medicine: Oncology, Brain Diseases and Cardiology
Current Radiopharmaceuticals Drugs and Rhabdomyolysis: From Liver to Kidney
Current Vascular Pharmacology Muscle Metabolism and Exercise Capacity in Cachexia
Current Pharmaceutical Design Recent Advances and Patents on Circulatory Support Devices for Pediatric Patients
Recent Patents on Biomedical Engineering (Discontinued) Targeting Molecular Imaging Approach for Detection of Infection and Inflammation by Diagnostic Nuclear Medicine Techniques
Current Medical Imaging Oxidized Haemoglobin–Driven Endothelial Dysfunction and Immune Cell Activation: Novel Therapeutic Targets for Atherosclerosis
Current Medicinal Chemistry Platelet-Derived Chemokines in Atherogenesis: What’s New?
Current Vascular Pharmacology Cell Immunity in Inflammatory Vasculitis
Current Immunology Reviews (Discontinued) Effects of Emotion and Stress on Lung Function in Health and Asthma
Current Respiratory Medicine Reviews Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine
Current Gene Therapy